Thursday, March 23, 2023
HomeStockAstraZeneca beats Q2 revenue and income estimates By Reuters

AstraZeneca beats Q2 revenue and income estimates By Reuters

© Reuters. FILE PHOTO: The brand for AstraZeneca is seen exterior its North America headquarters in Wilmington, Delaware, U.S., March 22, 2021. REUTERS/Rachel Wisniewski/File Photograph GLOBAL BUSINESS WEEK AHEAD

(Reuters) -AstraZeneca on Friday topped analyst expectations for second-quarter revenue and income, helped by increased demand for its most cancers medicines.

Core earnings got here in at $1.72 cents per share for the three months ended June 30, on income of about $10.8 billion.

Analysts on common had been anticipating revenue of $1.56 cents per share on income of round $10.5 billion, Refinitiv information confirmed.

The London-listed firm additionally raised its full-year income steerage, saying it expects it to rise by a share within the low twenties fairly than the excessive teenagers forecast beforehand.

On Friday, the corporate additionally revealed the substitute for non-executive Chairman Leif Johansson – Michel Demaré will take over as soon as Johansson retires subsequent yr. Demaré at the moment serves because the chair of AstraZeneca (NASDAQ:)’s remuneration committee.

Johansson turned chairman in 2012, across the identical time Frenchman Pascal Soriot took cost as chief government.



Please enter your comment!
Please enter your name here

Most Popular

Recent Comments